Table 2. Platelet inhibition rate in patients with different CYP2C19 genotypes.
| Groups | CYP2C19 gene | ADP-induced platelet inhibition rate | P-value | |
| Data are presented as n (%), mean ± SD. | ||||
| Normal metabolizer | *1*1 | 295 (43.7%) | 43.65 ± 28.18 | 0.001 |
| Intermediate metabolizer | *1*2 | 265 (39.3%) | 38.53 ± 29.60 | |
| *1*3 | 43 (6.4%) | |||
| Poor metabolizer | *2*2 | 56 (8.3%) | 29.61 ± 27.52 | |
| *2*3 | 14 (2.1%) | |||
| *3*3 | 2 (0.3%) | |||